AI entity
Every one of those 1 sits in a single category, ai-research. M-PACT is most often covered alongside DNA Methylation, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 3 original sources each against 4.5 for the same window.
Last mentioned: Feb 18, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, ai-research. M-PACT is most often covered alongside DNA Methylation, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 3 original sources each against 4.5 for the same window. Their average consequence score of 8 runs above the beat's 7.6 for that window. M-PACT appears in 1 tracked AI story from February 18, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 57 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering M-PACT. Shared-story counts are live from our verified record — not editorial picks.
Researchers at St. Jude Children’s Research Hospital have developed M-PACT, an AI tool that classifies pediatric brain tumors using liquid biopsy data. By analyzing DNA methylation patterns in cerebrospinal fluid, the tool offers a non-invasive alternative to traditional surgical biopsies.
M-PACT is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
